The decisions made at the NENC Medicines Subcommittee October 2023 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG at its September 2023 meeting and NICE Technology appraisals from the 1st June 2023 to 31st July 2023.
The following guidelines/position statements were approved and can be found at:
- Northern England Evaluation and Lipid Intensification guideline – updated https://ntag.nhs.uk/recommendations/cardiovascular-system-recommendations
- NENC At A Glance Supporting Greener Respiratory Care https://ntag.nhs.uk/recommendations/respiratory-system-recommendations/
- NENC Mucolytics in Adults Consensus Guide https://ntag.nhs.uk/recommendations/respiratory-system-recommendations/
- Abnormal Liver blood test Guidelines NENC Hepatology Network V2.2 https://ntag.nhs.uk/recommendations/miscellaneous-recommendations/
- North East Guideline For Use Of Sodium Glucose Co transporter 2 Inhibitors (SGLT2i) – updated – https://ntag.nhs.uk/recommendations/endocrine-system-recommendations/
- NENC Medication Management for Type 2 Diabetes in Adults Guidelines https://ntag.nhs.uk/recommendations/endocrine-system-recommendations/
- NENC Menopause guideline https://ntag.nhs.uk/recommendations/endocrine-system-recommendations/
The following guidelines will be published shortly once final version with version control on is received from the authors:
- NENC Amiodarone shared care guideline